Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Assets Average (2016 - 2025)

Guided Therapeutics (GTHP) has disclosed Assets Average for 14 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Assets Average fell 15.23% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, down 15.23% year-over-year, with the annual reading at $1.4 million for FY2025, 11.32% down from the prior year.
  • Assets Average hit $1.1 million in Q4 2025 for Guided Therapeutics, up from $921500.0 in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $3.6 million in Q4 2022 to a low of $921500.0 in Q3 2025.
  • Historically, Assets Average has averaged $1.9 million across 5 years, with a median of $1.9 million in 2021.
  • Biggest five-year swings in Assets Average: skyrocketed 239.13% in 2021 and later tumbled 51.0% in 2023.
  • Year by year, Assets Average stood at $1.9 million in 2021, then surged by 91.25% to $3.6 million in 2022, then plummeted by 51.0% to $1.8 million in 2023, then fell by 25.92% to $1.3 million in 2024, then fell by 15.23% to $1.1 million in 2025.
  • Business Quant data shows Assets Average for GTHP at $1.1 million in Q4 2025, $921500.0 in Q3 2025, and $953500.0 in Q2 2025.